CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.76B
AUM Growth
-$516M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$74.1M
2
+$60.6M
3
+$29.8M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$29.6M
5
IGMS
IGM Biosciences
IGMS
+$15.1M

Top Sells

1
+$47.5M
2
+$35.2M
3
+$33.2M
4
ASND icon
Ascendis Pharma
ASND
+$16.9M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$15.7M

Sector Composition

1 Healthcare 93.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$137M 6.34%
3,056,797
-339,853
2
$125M 5.79%
2,100,000
+109,078
3
$85.5M 3.98%
2,950,000
+437,135
4
$81.4M 3.78%
2,025,000
-875,000
5
$74.1M 3.45%
+825,000
6
$70.3M 3.27%
487,206
-329,194
7
$67M 3.11%
1,762,500
+265,000
8
$65.3M 3.04%
850,000
-432,392
9
$64.1M 2.98%
2,040,021
-259,979
10
$60.7M 2.82%
2,266,108
-433,892
11
$60.6M 2.82%
+2,767,078
12
$53.9M 2.5%
1,100,000
+604,308
13
$45.2M 2.1%
1,732,200
+129,824
14
$39.2M 1.82%
1,709,765
-78,878
15
$33.7M 1.57%
2,523,700
+998,700
16
$32.8M 1.52%
700,000
17
$29.8M 1.39%
+620,290
18
$29.8M 1.38%
875,551
-124,449
19
$29.4M 1.37%
500,000
-100,000
20
$28.2M 1.31%
250,000
-150,000
21
$27.6M 1.28%
61,950
-21,383
22
$26.7M 1.24%
630,400
-369,600
23
$26.3M 1.22%
450,000
+105,000
24
$24.8M 1.15%
700,000
25
$23.9M 1.11%
426,104
+269,704
1
2 3